{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:57:50Z","timestamp":1793642270450,"version":"4.5.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T00:00:00Z","timestamp":1424217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s10194-015-0496-6","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T02:50:07Z","timestamp":1424141407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries"],"prefix":"10.1186","volume":"16","author":[{"given":"Mattias","family":"Linde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,18]]},"reference":[{"key":"496_CR1","volume-title":"Atlas of headache disorders and resources in the world","author":"World Health Organization","year":"2011","unstructured":"World Health Organization, Lifting The Burden (2011) Atlas of headache disorders and resources in the world. WHO Press, Geneva"},{"issue":"9859","key":"496_CR2","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2163\u201396","journal-title":"Lancet"},{"issue":"4","key":"496_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3109\/15360280903328185","volume":"23","author":"J Yu","year":"2009","unstructured":"Yu J, Goodman MJ, Oderda GM (2009) Economic evaluation of pharmacotherapy of migraine pain: a review of the literature. J Pain Palliat Care Pharmacother 23(4):396\u2013408, doi:10.3109\/15360280903328185","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"8","key":"496_CR4","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/11531180-000000000-00000","volume":"24","author":"J Yu","year":"2010","unstructured":"Yu J, Smith KJ, Brixner DI (2010) Cost effectiveness of pharmacotherapy for the prevention of migraine: a Markov model application. CNS Drugs 24(8):695\u2013712, doi:10.2165\/11531180-000000000-000005","journal-title":"CNS Drugs"},{"issue":"5","key":"496_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","volume":"19","author":"M Linde","year":"2012","unstructured":"Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barre J, Katsarava Z, Lainez JM, Lampl C, Lanteri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andree C (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19(5):703\u201311, doi:10.1111\/j.1468-1331.2011.03612.x","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"496_CR6","first-page":"S3","volume":"8","author":"TJ Steiner","year":"2007","unstructured":"Steiner TJ, Paemeleire K, Jensen R, Valade D, Savi L, Lainez MJ, Lampl C, Lanteri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andree C (2007) European principles of management of common headache disorders in primary care. J Headache Pain 8(Suppl 1):S3\u201347, doi:10.1007\/s10194-007-0366-y","journal-title":"J Headache Pain"},{"issue":"9","key":"496_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","volume":"16","author":"S Evers","year":"2009","unstructured":"Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS, European Federation of Neurological S (2009) EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol 16(9):968\u201381","journal-title":"Eur J Neurol"},{"key":"496_CR8","unstructured":"WHO WHO model list of essential medicines. http:\/\/www.who.int\/selection_medicines\/list\/en\/index.html . Accessed Aug 5 2013"},{"issue":"5","key":"496_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.mjt.0000174354.05142.c1","volume":"13","author":"L Kelman","year":"2006","unstructured":"Kelman L, Von Seggern RL (2006) Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy. Am J Ther 13(5):411\u20137","journal-title":"Am J Ther"},{"issue":"3","key":"496_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","volume":"27","author":"L Stovner","year":"2007","unstructured":"Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193\u2013210","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"496_CR11","first-page":"9","volume":"24","author":"Headache Classification Subcommittee of the International Headache S","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache S (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24(Suppl 1):9\u2013160","journal-title":"Cephalalgia"},{"issue":"3","key":"496_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1098-3597(01)90039-0","volume":"4","author":"JU Adelman","year":"2001","unstructured":"Adelman JU, Lewit EJ (2001) Comparative aspects of triptans in treating migraine. Clin Cornerstone 4(3):53\u201364","journal-title":"Clin Cornerstone"},{"issue":"1","key":"496_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0333102411430849","volume":"32","author":"P Tfelt-Hansen","year":"2012","unstructured":"Tfelt-Hansen P, Pascual J, Ramadan N, Dahlof C, D'Amico D, Diener HC, Hansen JM, Lanteri-Minet M, Loder E, McCrory D, Plancade S, Schwedt T, International Headache Society Clinical Trials S (2012) Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia 32(1):6\u201338","journal-title":"Cephalalgia"},{"key":"496_CR14","unstructured":"Making choices in health: WHO guide to cost-effectiveness analysis (2003). World Health Organization, Geneva"},{"issue":"5","key":"496_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/0333102412438977","volume":"32","author":"I Ayzenberg","year":"2012","unstructured":"Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Yakhno N, Steiner TJ (2012) The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32(5):373\u201381","journal-title":"Cephalalgia"},{"issue":"7","key":"496_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10194-012-0474-1","volume":"13","author":"GN Rao","year":"2012","unstructured":"Rao GN, Kulkarni GB, Gururaj G, Rajesh K, Subbakrishna DK, Steiner TJ, Stovner LJ (2012) The burden of headache disorders in India: methodology and questionnaire validation for a community-based survey in Karnataka State. J Headache Pain 13(7):543\u201350, doi:10.1007\/s10194-012-0474-1","journal-title":"J Headache Pain"},{"issue":"6","key":"496_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10194-010-0264-6","volume":"11","author":"TJ Steiner","year":"2010","unstructured":"Steiner TJ, Birbeck GL, Jensen R, Katsarava Z, Martelletti P, Stovner LJ (2010) Lifting the burden: the first 7 years. J Headache Pain 11(6):451\u20135, doi:10.1007\/s10194-010-0264-6","journal-title":"J Headache Pain"},{"issue":"4","key":"496_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1526-4610.2011.02061.x","volume":"52","author":"S Yu","year":"2012","unstructured":"Yu S, Liu R, Zhao G, Yang X, Qiao X, Feng J, Fang Y, Cao X, He M, Steiner T (2012) The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 52(4):582\u201391","journal-title":"Headache"},{"key":"496_CR19","first-page":"CD008615","volume":"2","author":"CJ Derry","year":"2012","unstructured":"Derry CJ, Derry S, Moore RA (2012) Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2:CD008615, doi:10.1002\/14651858.CD008615.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"496_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1046\/j.1468-2982.2002.00404.x","volume":"22","author":"MD Ferrari","year":"2002","unstructured":"Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT1B\/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22(8):633\u201358","journal-title":"Cephalalgia"},{"key":"496_CR21","first-page":"CD008041","volume":"4","author":"V Kirthi","year":"2013","unstructured":"Kirthi V, Derry S, Moore RA (2013) Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD008041, doi:10.1002\/14651858.CD008041.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"496_CR22","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00415-004-0464-6","volume":"251","author":"HC Diener","year":"2004","unstructured":"Diener HC, Tfelt-Hansen P, Dahlof C, Lainez MJ, Sandrini G, Wang SJ, Neto W, Vijapurkar U, Doyle A, Jacobs D, Group MS (2004) Topiramate in migraine prophylaxis\u2013results from a placebo-controlled trial with propranolol as an active control. J Neurol 251(8):943\u201350, doi:10.1007\/s00415-004-0464-6","journal-title":"J Neurol"},{"key":"496_CR23","first-page":"CD010610","volume":"6","author":"M Linde","year":"2013","unstructured":"Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013) Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 6:CD010610, doi:10.1002\/14651858.CD010610","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"496_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.clinthera.2009.03.020","volume":"31","author":"DW Dodick","year":"2009","unstructured":"Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, Group C-I (2009) Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clin Ther 31(3):542\u201359, doi:10.1016\/j.clinthera.2009.03.020S0149-2918(09)00095-2","journal-title":"Clin Ther"},{"issue":"2","key":"496_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1526-4610.1997.3702088.x","volume":"37","author":"A Ferrari","year":"1997","unstructured":"Ferrari A, Stefani M, Sternieri S, Bertolotti M, Sternieri E (1997) Analgesic drug taking: beliefs and behavior among headache patients. Headache 37(2):88\u201394","journal-title":"Headache"},{"issue":"8","key":"496_CR26","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1368-5031.2004.00292.x","volume":"58","author":"N Savani","year":"2004","unstructured":"Savani N, Martin A, Browning D (2004) Switching patients with migraine from sumatriptan to other triptans increases primary care costs. Int J Clin Pract 58(8):758\u201363","journal-title":"Int J Clin Pract"},{"issue":"2","key":"496_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.18553\/jmcp.2005.11.2.137","volume":"11","author":"LR Etemad","year":"2005","unstructured":"Etemad LR, Yang W, Globe D, Barlev A, Johnson KA (2005) Costs and utilization of triptan users who receive drug prophylaxis for migraine versus triptan users who do not receive drug prophylaxis. J Manag Care Pharm 11(2):137\u201344","journal-title":"J Manag Care Pharm"},{"issue":"8","key":"496_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/j.1526-4610.2006.00435.x","volume":"46","author":"G Ifergane","year":"2006","unstructured":"Ifergane G, Wirguin I, Shvartzman P (2006) Triptans--why once? Headache 46(8):1261\u20133","journal-title":"Headache"},{"issue":"12","key":"496_CR29","first-page":"1057","volume":"55","author":"A Walling","year":"2006","unstructured":"Walling A, Woolley DC, Molgaard C, Kallail KJ (2006) Do family physicians fail to provide triptans for patients with migraine? J Fam Pract 55(12):1057\u201362","journal-title":"J Fam Pract"},{"issue":"3","key":"496_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1526-4610.2009.01343.x","volume":"49","author":"RK Cady","year":"2009","unstructured":"Cady RK, Maizels M, Reeves DL, Levinson DM, Evans JK (2009) Predictors of adherence to triptans: factors of sustained vs lapsed users. Headache 49(3):386\u201394","journal-title":"Headache"},{"key":"496_CR31","doi-asserted-by":"crossref","unstructured":"Berger A, Bloudek LM, Varon SF, Oster G (2012) Adherence with Migraine Prophylaxis in Clinical Practice. Pain Pract. doi:10.1111\/j.1533-2500.2012.00530.x","DOI":"10.1111\/j.1533-2500.2012.00530.x"},{"issue":"1","key":"496_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1345\/aph.1K354","volume":"42","author":"T Hedenrud","year":"2008","unstructured":"Hedenrud T, Jonsson P, Linde M (2008) Beliefs about medicines and adherence among Swedish migraineurs. Ann Pharmacother 42(1):39\u201345","journal-title":"Ann Pharmacother"},{"issue":"1","key":"496_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1468-2982.1998.1801052.x","volume":"18","author":"WM Mulleners","year":"1998","unstructured":"Mulleners WM, Whitmarsh TE, Steiner TJ (1998) Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. Cephalalgia 18(1):52\u20136","journal-title":"Cephalalgia"},{"issue":"12","key":"496_CR34","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1016\/j.clinthera.2008.12.010","volume":"30","author":"AZ Yaldo","year":"2008","unstructured":"Yaldo AZ, Wertz DA, Rupnow MF, Quimbo RM (2008) Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting. Clin Ther 30(12):2452\u201360","journal-title":"Clin Ther"},{"issue":"8","key":"496_CR35","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/jama.291.8.965","volume":"291","author":"JL Brandes","year":"2004","unstructured":"Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, Group M-S (2004) Topiramate for migraine prevention: a randomized controlled trial. JAMA 291(8):965\u201373","journal-title":"JAMA"},{"issue":"4","key":"496_CR36","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/archneur.61.4.490","volume":"61","author":"SD Silberstein","year":"2004","unstructured":"Silberstein SD, Neto W, Schmitt J, Jacobs D, Group M-S (2004) Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 61(4):490\u20135","journal-title":"Arch Neurol"},{"issue":"14","key":"496_CR37","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1177\/0333102411419681","volume":"31","author":"E Varkey","year":"2011","unstructured":"Varkey E, Cider A, Carlsson J, Linde M (2011) Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia 31(14):1428\u201338","journal-title":"Cephalalgia"},{"issue":"Suppl 2","key":"496_CR38","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1007\/s10072-007-0755-7","volume":"28","author":"SM Baskin","year":"2007","unstructured":"Baskin SM (2007) Managing the \u201cdifficult\u201d headache patient. Neurol Sci 28(Suppl 2):S78\u201383, doi:10.1007\/s10072-007-0755-7","journal-title":"Neurol Sci"},{"issue":"7","key":"496_CR39","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1526-4610.2009.01410.x","volume":"49","author":"M Bigal","year":"2009","unstructured":"Bigal M, Krymchantowski AV, Lipton RB (2009) Barriers to satisfactory migraine outcomes. What have we learned, where do we stand? Headache 49(7):1028\u201341","journal-title":"Headache"},{"issue":"7","key":"496_CR40","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1526-4610.2009.01471.x","volume":"49","author":"RW Evans","year":"2009","unstructured":"Evans RW, Linde M (2009) Expert opinion: adherence to prophylactic migraine medication. Headache 49(7):1054\u20138","journal-title":"Headache"},{"issue":"9","key":"496_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/j.1526-4610.2006.00582.x","volume":"46","author":"JC Rains","year":"2006","unstructured":"Rains JC, Penzien DB, Lipchik GL (2006) Behavioral facilitation of medical treatment for headache\u2013part II: Theoretical models and behavioral strategies for improving adherence. Headache 46(9):1395\u2013403","journal-title":"Headache"},{"key":"496_CR42","unstructured":"MSH International Drug Price Indicator Guide 2008. http:\/\/erc.msh.org\/dmpguide\/pdf\/DrugPriceGuide_2008_en.pdf . Accessed Sep 5 2013"},{"issue":"1","key":"496_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1129-2377-14-1","volume":"14","author":"TJ Steiner","year":"2013","unstructured":"Steiner TJ, Stovner LJ, Birbeck GL (2013) Migraine: the seventh disabler. J Headache Pain 14(1):1","journal-title":"J Headache Pain"},{"issue":"10","key":"496_CR44","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1046\/j.1526-4610.2002.02227.x","volume":"42","author":"JU Adelman","year":"2002","unstructured":"Adelman JU, Adelman LC, Von Seggern R (2002) Cost-effectiveness of antiepileptic drugs in migraine prophylaxis. Headache 42(10):978\u201383","journal-title":"Headache"},{"issue":"8","key":"496_CR45","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1526-4610.2005.05182.x","volume":"45","author":"JS Brown","year":"2005","unstructured":"Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J (2005) Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment. Headache 45(8):1012\u201322","journal-title":"Headache"},{"issue":"12","key":"496_CR46","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/j.1468-2982.2006.01240.x","volume":"26","author":"JS Brown","year":"2006","unstructured":"Brown JS, Papadopoulos G, Neumann PJ, Price M, Friedman M, Menzin J (2006) Cost-effectiveness of migraine prevention: the case of topiramate in the UK. Cephalalgia 26(12):1473\u201382","journal-title":"Cephalalgia"},{"key":"496_CR47","first-page":"CD008040","volume":"4","author":"S Derry","year":"2013","unstructured":"Derry S, Moore RA (2013) Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 4:CD008040, doi:10.1002\/14651858.CD008040.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"496_CR48","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10194-011-0320-x","volume":"12","author":"TJ Steiner","year":"2011","unstructured":"Steiner TJ, Antonaci F, Jensen R, Lainez MJ, Lanteri-Minet M, Valade D, European Headache F, Global Campaign against Headache (2011) Recommendations for headache service organisation and delivery in Europe. J Headache Pain 12(4):419\u201326, doi:10.1007\/s10194-011-0320-x","journal-title":"J Headache Pain"},{"issue":"6","key":"496_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10194-012-0465-2","volume":"13","author":"M Peters","year":"2012","unstructured":"Peters M, Jenkinson C, Perera S, Loder E, Jensen R, Katsarava Z, Gil Gouveia R, Broner S, Steiner T (2012) Quality in the provision of headache care. 2: defining quality and its indicators. J Headache Pain 13(6):449\u201357, doi:10.1007\/s10194-012-0465-2","journal-title":"J Headache Pain"},{"key":"496_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1129-2377-14-101","volume":"14","author":"ER Lebedeva","year":"2013","unstructured":"Lebedeva ER, Olesen J, Osipova VV, Volkova LI, Tabeeva GR, Steiner TJ (2013) The Yekaterinburg headache initiative: an interventional project, within the Global Campaign against Headache, to reduce the burden of headache in Russia. J Headache Pain 14:101","journal-title":"J Headache Pain"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-015-0496-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-015-0496-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-015-0496-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-015-0496-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T21:26:37Z","timestamp":1651267597000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-015-0496-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,18]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1186\/s10194-015-0496-6","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,18]]},"article-number":"15"}}